Introduction
Hemostasis has been proposed as a possible pathogenetic factor in dementia, especially vascular dementia [1] [2] [3] . To our knowledge there is only one study by Mari et al [1] in which endothelial derived fibrinolytic markers and vWF has been evaluated in AD vs. VaD patients.
In the fibrinolytic system plasmin is regulated by tissue plasminogen activator The metabolic syndrome, also characterized by an atherosclerotic tendency, is associated with increased plasma levels of the fibrinolytic key components PAI-1 and 
Materials and Methods

Study population
The present study comprises two different Csf signs of AD and albumin index [16] was significantly higher in the VaD group compared with AD group. There were no post-mortem data. Mental State Examination, MMSE [17] and Clock Drawing Test, CDT [18, 19] .
According to these tests they were all cognitively intact with MMSE ≥28 and CDT ≥ 4. Since the subjects were drawn from an accessible population and do not represent a random population sample of elderly Swedes, we designated this referent group as 'Active Seniors' (AS-study group).
Blood samples were taken on subjects in sitting position after a minimum of 15 minutes rest in order to diminish effects of acute physical activity on the biomarkers.
There are no medical history data and no physical examination data besides blood pressure and blood sample analyses.
Our study thus comprised three groups: AS 
Statistical analyses
Statistical analyses were performed using SPSS Numbers are given in the tables.
Ethics
The studies were performed in accordance 
Results
We studied 304 subjects of whom 95 were diagnosed as AD and 55 as VaD and 154 subjects comprised the referent group of AS.
The basic characteristics of the subjects are shown in Table 1 Post hoc effects are compared according to Bonferroni, figures are given in italics.
AD, a picture shared by several recent authors [30] [31] [32] . From 1996-98 onwards, the hyperhomocysteinemic aspect of VaD (and AD) has attracted attention [33] [34] [35] [36] An increase in hs-CRP may probably per se cause increased plasma tPA concentrations [29] . In our study we have shown ( Table 1) that hs-CRP is significantly lower in AD Table 2 were adjusted for hs-CRP.
Mari et al. [1] 
